Regenovue DEEP 1x1ml

Regenovue DEEP 1x1ml

High-quality hyaluronic acid with medium particle size and medium degree of cross-linking.

Thanks to its regular and compact structure, it gives a natural volume effect that lasts for a long time.

The preparation is smooth and comfortable for both the patient and the doctor.

Indications

• Filling medium wrinkles and labial-nasal folds,
• Correction of the zygomatic bone and chin,
• Contouring and enlarging lips,
• Treatment of deep "lion's wrinkle" wrinkles.

Persistence of the effect

12-18 months

Injection area

The middle layer of the dermis

The preparation contains:

Hyaluronic acid 24 mg/ml
Low endotoxin concentration – below 0.1 EU/g

Packaging

1 syringe x 1 ml of the preparation
2 x 27G needle

CONTRAINDICATIONS

The product is contraindicated:

- In patients with severe allergy manifesting itself or the presence of multiple severe allergies,

- In patients with a history of facial keloid or hypertrophic scar,

- In patients with known hypersensitivity to one of the ingredients of the product, especially sodium hyaluronate,

- In patients with porphyria,

- In pregnant or breastfeeding women,

- In young patients under 18 years of age,

- In patients with active (or previous) autoimmune disease.

Do not use if you have active disease such as inflammation, infection or tumors at or near the treatment site.

Do not inject into the periorbital area (eyelids, dark circles under the eyes, crow's feet) or glabellar area because there is a risk of eye ischemia, an event leading to loss of vision.

Do not inject intravascularly. Introduction of the product into the vascular system may lead to embolization, vascular occlusion, ischemia or infarction,

Rare but serious adverse events associated with intravascular injection of soft tissue fillers into the face have been reported and include temporary or permanent visual disturbances, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, and damage to underlying facial structures.

Stop the injection immediately if you experience any of the following symptoms, including vision changes, signs of stroke, skin turning pale, or unusual pain during or immediately after the procedure.

Patients should receive immediate medical attention and possibly intravascular injection.

Do not use in patients with:

History of streptococcal disease (recurrent throat infections, acute rheumatic fever with or without cardiac involvement),

Patients taking substances that affect platelet function such as aspirin and non-steroidal anti-inflammatory drugs or high doses of vitamin C may, as with any injection, experience increased bruising or bleeding at the injection sites.

ADVERSE EVENTS

Patients must be informed of the potential risks and adverse events associated with the injection procedure and use of this product.

During the injection, slight bleeding may occur which disappears as soon as the injection is completed, occasionally, one or more of the following may occur immediately or as a delayed reaction (the list is not exhaustive):
Reactions commonly associated with injections such as redness, erythema, swelling or pain. These reactions may last for a week:

• Hematomas in the treated area,
• Swelling in the treated area
• Hardness or lumps in the treated area
• Coloring or discoloration in the treated area
• Poor effect or poor filling effect,
• Coloring or discoloration in the treated area
• Poor effect or poor filling effect,
• Allergy to one of the ingredients of the product, especially sodium hyaluronate.

Cases of necrosis, abscesses and granulomas after soda injections have been described in the literature.

However, these rare potential risks should be taken into account.

Patients should be advised to report any adverse reactions that persist for:

More than a week to see your doctor.

The doctor can then prescribe appropriate treatment for the patient,

Any other adverse side effects associated with injection of the product should be reported to the distributor and/or manufacturer.

Before the procedure, patients should be informed about the indications.

The procedure must be performed under appropriate aseptic conditions.

The products are intended for professional use.